Live Breaking News & Updates on Roberti blum

Stay updated with breaking news from Roberti blum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cytokinetics Target of Unusually High Options Trading (NASDAQ:CYTK)

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) was the recipient of some unusual options trading activity on Friday. Stock investors acquired 267,109 call options on the stock. This represents an increase of 1,648% compared to the typical daily volume of 15,277 call options. Cytokinetics Price Performance Shares of CYTK opened at $84.95 on Friday. Cytokinetics […]

Roberti-blum , Fady-ibraham-malik , Financial-services-group-inc , Cytokinetics-incorporated , Cytokinetics-company-profile , Belpointe-asset-management , Needham-company , Cantor-fitzgerald , Victory-capital-management-inc , Mirae-asset-global-investments-co , Get-free-report , Ibraham-malik

Cytokinetics (NASDAQ:CYTK) Downgraded by StockNews.com

StockNews.com lowered shares of Cytokinetics (NASDAQ:CYTK – Free Report) from a hold rating to a sell rating in a report published on Friday. A number of other analysts have also commented on the stock. Needham & Company LLC lifted their target price on shares of Cytokinetics from $60.00 to $108.00 and gave the stock a […]

United-states , America , Fady-ibraham-malik , Roberti-blum , Norges-bank , America-corp , Goldman-sachs-group , Cytokinetics-company-profile , Vanguard-group-inc , Blackrock-inc , Securities-exchange-commission , Needham-company

Cytokinetics (NASDAQ:CYTK) Given Equal Weight Rating at Morgan Stanley

Morgan Stanley reissued their equal weight rating on shares of Cytokinetics (NASDAQ:CYTK – Free Report) in a research note published on Friday morning, MarketBeat.com reports. They currently have a $90.00 price objective on the biopharmaceutical company’s stock, up from their prior price objective of $60.00. A number of other analysts have also issued reports on […]

United-states , America , Fady-ibraham-malik , Roberti-blum , Cytokinetics-incorporated , Morgan-stanley , Cantor-fitzgerald , Cytokinetics-company-profile , Vanguard-group-inc , Goldman-sachs-group , Pricet-rowe-associates-inc , Securities-exchange-commission

Cytokinetics (NASDAQ:CYTK) Downgraded by StockNews.com

StockNews.com downgraded shares of Cytokinetics (NASDAQ:CYTK – Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning. Several other equities analysts also recently issued reports on CYTK. The Goldman Sachs Group started coverage on Cytokinetics in a research report on Thursday, November 9th. They set […]

Montreal , Quebec , Canada , Roberti-blum , Raymond-james , Fady-ibraham-malik , Raymond-james-associates , Jpmorgan-chase-co , Financial-services-group-inc , Goldman-sachs-group , Advisor-group-holdings-inc , Cytokinetics-incorporated

Morgan Stanley Reaffirms Equal Weight Rating for Cytokinetics (NASDAQ:CYTK)

Morgan Stanley Reaffirms Equal Weight Rating for Cytokinetics (NASDAQ:CYTK)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Fady-ibraham-malik , Raymond-james , Roberti-blum , Cytokinetics-incorporated , Securities-exchange-commission , Belpointe-asset-management , Cantor-fitzgerald , Needham-company , Cytokinetics-company-profile , Victory-capital-management-inc , Financial-services-group-inc , Mirae-asset-global-investments-co

Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San-francisco , California , United-states , Cytokinetics-diane-weisersenior , Roberti-blum , Corporate-communications , Francis-hotel , Youtube , Exchange-commission , Linkedin , Cytokinetics-incorporated , Facebook

Cytokinetics To Present At The 42Nd Annual J.P. Morgan Healthcare Conference

Cytokinetics To Present At The 42Nd Annual J.P. Morgan Healthcare Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

San-francisco , California , United-states , Diane-weiser , Roberti-blum , Corporate-communications , Youtube , Facebook , Linkedin , Francis-hotel , Exchange-commission , Cytokinetics-incorporated-nasdaq

Cytokinetics (NASDAQ:CYTK) Upgraded at StockNews.com

Cytokinetics (NASDAQ:CYTK) Upgraded at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Roberti-blum , Raymond-james , Goldman-sachs-group , Needham-company , Cytokinetics-incorporated , Mirae-asset-global-investments-co , Financial-services-group-inc , Victory-capital-management-inc , Belpointe-asset-management , Free-report , Moderate-buy , Get-free-report

Truist Financial Boosts Cytokinetics (NASDAQ:CYTK) Price Target to $86.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective raised by Truist Financial from $60.00 to $86.00 in a report released on Thursday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. Several other research firms have also commented on CYTK. Cantor Fitzgerald boosted their price objective on Cytokinetics from […]

Montreal , Quebec , Canada , Roberti-blum , Fady-ibraham-malik , Goldman-sachs-group , Jpmorgan-chase-co , Raymond-james-associates , Advisor-group-holdings-inc , Cantor-fitzgerald , Securities-exchange-commission , Cytokinetics-incorporated

HC Wainwright Boosts Cytokinetics (NASDAQ:CYTK) Price Target to $94.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its target price lifted by HC Wainwright from $58.00 to $94.00 in a report released on Wednesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on the company. The Goldman Sachs Group began […]

China , Roberti-blum , Fady-ibraham-malik , China-universal-asset-management-co , Goldman-sachs-group , Securities-exchange-commission , Chilton-capital-management , Belpointe-asset-management , Tower-group , Cantor-fitzgerald , Cytokinetics-incorporated , Needham-company